SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Cardiovascular Pharmacology and Therapeutics
This Article
Right arrow Full Text (OnlineFirst PDF)
Right arrow All Versions of this Article:
1074248409347986v1
14/4/302    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Zhang, D.
Right arrow Articles by Bi, Y.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, D.
Right arrow Articles by Bi, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Sodium Ferulate Modified Gene Expression Profile of Oxidized Low-Density Lipoprotein-Stimulated Human Umbilical Vein Endothelial Cells

Dongxian Zhang, MD1, Zhuoyue Bi, MD2*, Yang Li, MD, PhD3, Hong Zheng, MD4, Li Li, MD5, Jingping Ouyang, MD6, Baohua Wang, MD, PhD6, and Yongyi Bi, MD, PhD5

1 School of Public Health, Wuhan University, Wuhan, Hubei, PR China; Nanyang Medical College, Henan, PR China
2 School of Pharmacy, Wuhan University, Wuhan, PR China
3 Hubei Provincial Center for Disease Control and Prevention, Wuhan, PR China
4 School of Basic Medical Science, Yunyang Medical College, Hubei, PR China
5 School of Public Health, Wuhan University, Wuhan, Hubei, PR China
6 Department of Pathology and Pathophysiology, School of Medicine, Wuhan University, Wuhan, PR China

* To whom correspondence should be addressed. E-mail: bizhuoyue{at}yahoo.cn.


   Abstract
Oxidized low-density lipoprotein (ox-LDL) is known to trigger vascular injury in atherosclerosis development. Sodium ferulate is an effective component from Chinese medicines with various beneficial cardiovascular pharmacological activities. Here, we investigated the effects of sodium ferulate on the gene expression profile of ox-LDL-stimulated endothelial cells. Cultured human umbilical vein endothelial cells (HUVECs) were treated with ox-LDL (50 μg/mL) in the absence or presence of sodium ferulate (5 μmol/L). Sodium ferulate significantly reduced ox-LDL-induced endothelial cell death as evaluated by cell viability assay. Human oligonucleotide microarray analysis demonstrated that a total of 32 ox-LDL-induced genes were significantly downregulated to control levels by sodium ferulate. These genes included members from families of chemokine, inflammatory factor, growth factor, and nuclear receptor. These data provided an overview of the gene expression profile of endothelial cells in response to ox-LDL and sodium ferulate, and demonstrated that sodium ferulate could regulate the expression of inflammation-related genes in endothelial cells and has the potential to benefit endothelial function in the setting of atherosclerosis.

First published on October 16, 2009, doi:10.1177/1074248409347986

Journal of Cardiovascular Pharmacology and Therapeutics 2009;14:302.

A more recent version of this article appeared on December 1, 2009


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement